| 000 | 01748 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250513120113.0 | ||
| 264 | 0 | _c19970605 | |
| 008 | 199706s 0 0 eng d | ||
| 022 | _a0007-0920 | ||
| 024 | 7 |
_a10.1038/bjc.1997.213 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBjørge, L | |
| 245 | 0 | 0 |
_aResistance of ovarian teratocarcinoma cell spheroids to complement-mediated lysis. _h[electronic resource] |
| 260 |
_bBritish journal of cancer _c1997 |
||
| 300 |
_a1247-55 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xpharmacology |
| 650 | 0 | 4 |
_aAntibody-Dependent Cell Cytotoxicity _ximmunology |
| 650 | 0 | 4 |
_aAntigens, CD _xbiosynthesis |
| 650 | 0 | 4 |
_aCD55 Antigens _xbiosynthesis |
| 650 | 0 | 4 |
_aCD59 Antigens _xbiosynthesis |
| 650 | 0 | 4 | _aComplement Activation |
| 650 | 0 | 4 |
_aComplement Inactivator Proteins _xbiosynthesis |
| 650 | 0 | 4 |
_aComplement System Proteins _xphysiology |
| 650 | 0 | 4 |
_aCytotoxicity, Immunologic _xdrug effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFlow Cytometry |
| 650 | 0 | 4 | _aFluorescent Antibody Technique, Indirect |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMembrane Cofactor Protein |
| 650 | 0 | 4 |
_aMembrane Glycoproteins _xbiosynthesis |
| 650 | 0 | 4 |
_aOvarian Neoplasms _ximmunology |
| 650 | 0 | 4 |
_aSpheroids, Cellular _ximmunology |
| 650 | 0 | 4 |
_aTeratocarcinoma _ximmunology |
| 650 | 0 | 4 | _aTumor Cells, Cultured |
| 700 | 1 | _aJunnikkala, S | |
| 700 | 1 | _aKristoffersen, E K | |
| 700 | 1 | _aHakulinen, J | |
| 700 | 1 | _aMatre, R | |
| 700 | 1 | _aMeri, S | |
| 773 | 0 |
_tBritish journal of cancer _gvol. 75 _gno. 9 _gp. 1247-55 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/bjc.1997.213 _zAvailable from publisher's website |
| 999 |
_c9136332 _d9136332 |
||